![N-(4-{[4-(dimethylamino)quinazolin-2-yl]amino}cyclohexyl)-3,4-difluorobenzamide hydrochloride](https://static.cymitquimica.com/cas-image/299237-n-4-4-dimethylamino-quinazolin-2-yl-amino-cyclohexyl-34-difluorobenzamide-hydrochloride.png)
CAS: 510733-97-8 - N-(4-{[4-(dimethylamino)quinazolin-2-yl]amino}cyclohexyl)-3,4-difluorobenzamide hydrochloride
Fórmula:C23H26ClF2N5O
InChI:InChI=1/C23H25F2N5O.ClH/c1-30(2)21-17-5-3-4-6-20(17)28-23(29-21)27-16-10-8-15(9-11-16)26-22(31)14-7-12-18(24)19(25)13-14;/h3-7,12-13,15-16H,8-11H2,1-2H3,(H,26,31)(H,27,28,29);1H
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | ATC0175 REF: IN-DA00DGTACAS: 510733-97-8 | 98% | A consultar | Mar 07 Ene 25 |
 | ATC0175 REF: 7W-GL1008CAS: 510733-97-8 | - - - | A consultar | Mar 07 Ene 25 |
 | ATC0175 REF: 3D-KVA73397CAS: 510733-97-8 | Min. 95% | A consultar | Mar 18 Feb 25 |
 | ATC 0175 hydrochloride REF: TM-T22591CAS: 510733-97-8 | 99.84% | 78,00 €~2.777,00 € | Mar 25 Feb 25 |
Ref: IN-DA00DGTA
| 10mg | 601,00 € | ||
| 25mg | A consultar | ||
| 50mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 7 de Enero de 2025
Ref: 7W-GL1008
| Tamaño no definido | A consultar |
Entrega estimada en Estados Unidos, el Martes 7 de Enero de 2025
ATC0175
CAS:510733-97-8
ATC0175 is a synthetic analog of the natural fatty acid, gamma-aminobutyric acid (GABA). It has …
Fórmula:
C23H26ClF2N5O
Pureza:
Min. 95%
Peso molecular:
461.94 g/mol
Ref: 3D-KVA73397
| 5mg | A consultar | ||
| 10mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 18 de Febrero de 2025
ATC 0175 hydrochloride
CAS:510733-97-8
ATC 0175 hydrochloride is an orally active melanocyte concentrating hormone 1 receptor antagonist that is …
Fórmula:
C23H26ClF2N5O
Pureza:
99.84%
Forma y color:
Solid
Peso molecular:
461.93
Ref: TM-T22591
| 1mg | 78,00 € | ||
| 5mg | 157,00 € | ||
| 10mg | 245,00 € | ||
| 25mg | 502,00 € | ||
| 50mg | 852,00 € | ||
| 100mg | 1.384,00 € | ||
| 500mg | 2.777,00 € |
Entrega estimada en Estados Unidos, el Martes 25 de Febrero de 2025
